| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $19.3M | +8.7% | +15.1% |
| SG&A Expense | $4.7M | +14.1% | +62.5% |
| Operating Income | -$23.9M | -9.7% | -22.0% |
| Net Income | -$21.6M | -11.4% | -19.2% |
| EPS (Basic) | -$0.63 | -8.6% | +77.3% |
| EPS (Diluted) | -$0.63 | -8.6% | +77.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $223.1M | +460.9% | +67.9% |
| Short-term Investments | $168.5M | -9.0% | +16.9% |
| Current Assets | $397.5M | +73.4% | +41.4% |
| Total Assets | $400.1M | +72.8% | +41.7% |
| Current Liabilities | $12.1M | +2.6% | +10.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$61.6M | — | — |
| Capital Expenditures | $1.1M | — | — |
| Investing Cash Flow | $46.3M | — | — |
| Financing Cash Flow | $189.2M | — | — |
| Free Cash Flow | -$62.8M | — | — |
| $12.5M |
| +2.1% |
| +13.7% |
| Stockholders' Equity | $387.5M | +76.8% | +42.8% |